Coding Billing

Total Page:16

File Type:pdf, Size:1020Kb

Coding Billing Coding&Billing Quarterly FEBRUARY 2015 EDITOR ALAN L. PLUMMER, MD ATS RUC Advisor Letter from the Editor Welcome to the January 2015 edition of the ATS Coding ADVISORY BOARD MEMBERS: and Billing Quarterly. The New Year will bring a number of KATINA NICOLACAKIS, MD important changes to medicine for practitioners of pulmonary, Chair, ATS Clinical Practice Committee ATS Alternate RUC Advisor critical care and sleep medicine. Below are some issues that ATS STEPHEN P. HOFFMANN, MD members and their staff need to be aware of and prepared for: Member, ATS Clinical Practice Committee ATS CPT Advisor ICD-10 Transition – Barring another last minute intervention MICHAEL NELSON, MD by Congress (which is possible but very unlikely), 2015 will Member, ATS Clinical Practice Committee be the year of the ICD-10 transition. I hope providers and ATS Alternate CPT Advisor practices are well underway preparing for the transition. Over the past year, the STEVE G. PETERS, MD Member, ATS Clinical Practice Committee ATS Coding and Billing Quarterly has featured articles on the transition. The April 2015 edition will cover ICD-10 for pediatric pulmonary services. Lung Cancer Screening Coverage – Earlier this month, the Centers for Medicare In This Issue and Medicaid Services (CMS) released its final coverage policy for lung cancer Low Dose CT Lung Cancer screening. In this issue, Dr. Kovitz describes the final coverage policy, its impact Screening Coverage - Implications on Medicare and private coverage, as well as tips for coding services related to for the Practitioner, page 2 screening. 2015 Brings New Extracorporeal Membrane Oxygenation New ECMO codes – Also covered in this issue is the new and expanded family of (ECMO)/Extracorporeal Life codes for EMCO services. Dr. Hussain describes the new codes and how they will Support (ECLS) Common likely be used by pediatric and adult providers. Procedural Terminology (CPT) codes, page 5 Sustainable Growth Rate Factor – Yes, the looming SGR problem is still with us. Despite the significant progress made by Congress last year, they still were unable Q&A, page 8 to pass a permanent fix to the SGR crisis and for the 17th time, passed a short- term patch. The short-term patch extended the 0.5% Medicare update through 2014 – please note, providers will see a 0.5% cut in reimbursement starting January 1, 2015 – and delayed the 24% SGR payment cut through March 31, 2015. So once again, Congress will start the New Year having to act fast on an SGR bill – or jeopardize destabilizing the Medicare program. While the above issues are on the ATS radar screen, I am confident 2015 will hold many more surprises and challenges for the pulmonary, critical care and sleep community. We will continue to do our best to share timely and accurate information with ATS members on billing, coding and regulatory compliance issues. Sincerely, Alan L. Plummer, MD Editor Physician’s Current Procedural Terminology (CPT®) codes, descriptions, and numeric modifiers are © 2014 by the American Medical Association. All rights reserved. 1 ATS Coding&BillingQuarterly FEBRUARY 2015 LOW DOSE CT (LDCT) LUNG CANCER SCREENING COVERAGE—IMPLICATIONS FOR THE PRACTITIONER Kevin L Kovitz, MD, MBA of the supporting data. According to the Affordable Care Professor of Medicine and Surgery, University of Illinois at Act, 3 all preventative services that received an A or B grade Chicago and Director, Chicago Chest Center from the USPSTF must be covered by private insurance at No Conflicts. no costs to the consumer.3 Commercial carriers are required National coverage for lung cancer screening has arrived. In incorporate category A and B recommendations with the February 2015, Centers for Medicare & Medicaid Services plans annual renewal. It is important to note that the annual (CMS) issued a final coverage policy. Heretofore, screening renewal date for private plans can happen through the programs have had varying levels of success in attracting calendar year. Private insurance coverage for lung cancers providers and patients alike with the major barrier being lack screening did not necessarily start in January for private of reimbursement. The purpose of this discussion is separate patients. Providers should consult with patients and insurance from the utility of screening. Rather, the focus is on obtaining companies to ensure lung cancer screening is covered. coverage for the patient encounters and scans required. The Age and Coverage Policy Affordable Care Act and the CMS lung cancer screening The coverage criteria are similar in all respects aside from policy significantly change coverage. age. This is not an issue in most situations as the 55-64 year There are 2 main areas to understand, CMS coverage and old and the 65-77 year old with commercial insurance or commercial carrier coverage. Medicare should be covered. The most common scenario is CMS Coverage of the younger patient with commercial insurance and the From a CMS perspective, we can take the specific older group with Medicare. Interestingly, the 78-80 year old criteria from their announcement.1 The ATS, like many with Medicare is not covered unless they have commercial organizations, submitted comments to improve and clarify insurance as primary coverage. The commercially insured the initial CMS proposal. Specifically, the ATS recommended older patient is likely to represent a small group and CMS extending the screening coverage to include Medicare coverage is an issue if one is of the opinion that screening beneficiaries aged 75-80, sought clarification on the shared needs to be done in this age group. decision making visits, recommended clarifying language Coding on the term “asymptomatic” and noted the importance of Coding is multifactorial. However, there is no specific CPT a multidisciplinary team in diagnosing and managing lung code for the Evaluation and Management of a patient that cancer. The final CMS policy addresses these issues, with presents for Lung Cancer Screening evaluation. Traditional the age reaching 77, shared decision making clarified, and outpatient consults (where applicable), new patient or “asymptomatic” focused to symptoms related to lung cancer. established patient E & M coding should be used. The E & Practitioners and programs should carefully review the final M selected must be commensurate with the level of service policy prior to establishing a site-specific screening protocol. as determined by specific actions or counseling as one would The CMS proposal is very detailed, mostly follows the with any visit. The diagnoses may include, but are not limited National Lung Screening Trial (NLST) criteria, and to: special screening for malignant neoplasm of the respiratory requires specific personnel, shared decision making with organs, V76.0 (ICD-9) or Z12.2 (ICD-10)4 and all diagnoses the patient, specific documentation, smoking cessation appropriate to the patient’s problems. Consider including counseling, detailed orders, specific radiology requirements, a code for the tobacco history such as nicotine dependence and participation in a registry. The specific CMS decision (ICD-9 305.1, ICD-10 F17.200) or history of same (ICD-9 summary of the policy, copied directly from the website, is V15.82, ICD-10 Z87.891). The tobacco code is not specified noted below1 for reference as there are extensive and very but makes sense as these patients need a smoking history and detailed requirements. Please review these carefully. pack years need to be documented in order to qualify for Private Insurance screening. The radiologist will have a specific HCPCS code of S8032 Commercial carriers face a different issue. As most are aware, Low-dose computed tomography for lung cancer screening.5 the USPSTF has recommended lung cancer screening for a broader age range.2 The grade of B was given for the validity continued on page 3 2 Physician’s Current Procedural Terminology (CPT®) codes, descriptions, and numeric modifiers are © 2014 by the American Medical Association. All rights reserved. ATS Coding&BillingQuarterly FEBRUARY 2015 continued from page 2 The above summary reflects the current point in time. by a physician (as defined in Section 1861(r)(1) of Practitioners and programs are urged to carefully review the the Social Security Act) or qualified non-physician final policy before establishing program policies. Additionally, practitioner (meaning a physician assistant, nurse it is important to review the policies of individual commercial practitioner, or clinical nurse specialist as defined in carriers as they often differ from CMS. §1861(aa)(5) of the Social Security Act). A lung cancer screening counseling and shared decision making visit References includes the following elements (and is appropriately 1. http://www.cms.gov/medicare-coverage-database/details/ documented in the beneficiary’s medical records): nca-decision-memo.aspx?NCAId=274 accessed 2/10/15). • Determination of beneficiary eligibility including age, See below. absence of signs or symptoms of lung cancer, a specific calculation of cigarette smoking pack-years; and if a former 2. Moyer VA on behalf of the U.S. Preventive Services Task smoker, the number of years since quitting; Force. Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. • Shared decision making, including the use of one or more 2014;160(5):330-338. decision aids, to include benefits and harms of screening, follow-up diagnostic testing, over-diagnosis, false positive 3. http://www.law.cornell.edu/cfr/text/29/2590.715-2713
Recommended publications
  • Central Venous Access with Accelerated Seldinger Technique Versus Modified Seldinger Technique
    Central Venous Access with Accelerated Seldinger Technique versus Modified Seldinger Technique L A N E THAUT , D O , CAPT , M C , USAF SAN ANTONIO MILITARY MEDICAL CENTER CO- AUTHORS: WELLS WEYMOUTH, MD, DANIEL RESCHKE, MD, BRANDEN HUNSAKER,MD Disclosures Expired POWERWAND™ combination device kits were donated by Access Scientific for the express purpose to be used in this study; however, no other contributions were made. We approached Access Scientific to obtain the devices to conduct this study. No financial relationship with Access Scientific. Background Techniques Research and Outcomes Questions Background Air Force SAMMC San Antonio, TX Level 1 Trauma Center 85,000+ patients annually Central Access Common Procedure Approximately 8% of hospitalized patients Multiple indications Large volume fluid or blood product resuscitation Administration of central acting medications Multiple medications simultaneously Trans venous pacing Difficult peripheral access Quick Story What if there was a simpler/quicker way? Intra-osseous? Complications Slower Flow Rate Labs Traditional Central Line Multiple steps/parts Midlines Usually used for extended dwelling lines. Self contained, all in one device. Equivalent and sometimes superior flow rate. Question Will the use of combination devices (midline/POWERWAND™) and the associated accelerated technique reduce the time of CVC placement? VS What is Accelerated Seldinger Technique? Needle, guidewire, dilator, and sheath into one. The device needle is inserted into the target vein under ultrasound guidance and a flash is observed The internal guidewire is then advanced into the vein and snapped into the needle hub. Dilator collar is turned and the dilator and sheath are advanced The dilator hub is disengaged from the needle hub, and the guidewire, dilator, and needle are all removed as a single unit.
    [Show full text]
  • Practice Parameter for the Use of Ultrasound to Guide Vascular Access Procedures
    PRACTICE GUIDELINES AIUM Practice Parameter for the Use of Ultrasound to Guide Vascular Access Procedures I. Introduction he clinical aspects of this parameter were developed collaboratively among the AIUM and other organizations whose members use ultrasound for guidance in vascular T “ ” access procedures (see Acknowledgments ). Recommendations for practitioner requirements, the written request for the examination, procedure documentation, and quality control vary among the organizations and are addressed by each separately. This parameter has been developed by and for clinicians from diverse specialties and practitioner levels who perform vascular access. While vascular access may be performed using external landmarks, point-of-care ultrasound is now increasingly available.1 Appropriately used, ultrasound guidance for vascular access has been shown to improve success rates while reducing iatrogenic injury, the number of needle passes, and infection rates.2 Addition- ally, it may improve patient comfort and satisfaction. This parameter is intended to be evidence based when possi- ble and to include selected references of importance, but it is not meant to be a comprehensive or rigorous literature review, as this has been accomplished elsewhere.3 The intent of this document is to highlight appropriate evidence while also providing a practical, real-world expert consensus from clinicians with diverse back- grounds on the best use and techniques for incorporating ultra- sound into vascular access procedures with the ultimate goal of improving the care of our patients. II. Indications/Contraindications Ultrasound should be used to aid in central venous, peripheral venous, and arterial access procedures.4 When used appropriately by qualified personnel, there are no absolute contraindications to using ultrasound as a procedural adjunct for vascular guidance.
    [Show full text]
  • Too Many Twos in One Patient: Two Central Venous Catheters, Two
    & Experim l e ca n i t in a l l C Journal of Clinical and Experimental C f a o r d l i a o Chalwade, J Clin Exp cardiolog 2018, 9:9 n l o r g u y o Cardiology DOI: 10.4172/2155-9880.1000605 J ISSN: 2155-9880 Case Report Open Access Too Many Twos in One Patient: Two Central Venous Catheters, Two Routes, Two Hospitals, Two Lost Guidewires, Two Vascular Systems, One Patient Rahul Chalwade* Department of Cardiology, Felix Health Care, Noida, Uttar Pradesh, India *Corresponding author: Rahul Chalwade, Department of Cardiology, Felix Health Care, Noida, Uttar Pradesh, India, Phone: +919717053558; E-mail: [email protected] Received date: September 05, 2018; Accepted date: September 10, 2018; Published date: September 17, 2018 Copyright: © 2018 Chalwade R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Central venous catheter insertion by Seldinger's technique is a very common procedure nowadays. The technique though considered safe, is associated with potential dreaded complications. One such complication is intravascular loss of guidewire during insertion. We describe one unusual case of two chronically lost guidewires in venous and arterial system with successful retrieval by innovative interventional techniques. Keywords: Lost guidewire; Interventional cardiology; Interventionl AORTA-ARCH OF AORTA-LOOPING IN DESCENDING AORTA- radiology; Central venous catheter complications; Anaesthesiology; OPENING OF LT SCA (straight tip of guidewire). Snare We did routine blood evaluation, all were normal, venous and arterial Doppler and echo was done to rule out thrombus.
    [Show full text]
  • First Simulator for Seldinger Technique and Angiography Training
    This is a repository copy of ImaGiNe Seldinger: first simulator for Seldinger Technique and Angiography Training. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/79950/ Version: Accepted Version Article: Luboz, V, Zhang, Y, Johnson, S et al. (20 more authors) (2013) ImaGiNe Seldinger: first simulator for Seldinger Technique and Angiography Training. Computer Methods and Programs in Biomedicine, 111 (2). 419 - 434. ISSN 0169-2607 https://doi.org/10.1016/j.cmpb.2013.05.014 Reuse Unless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy solely for the purpose of non-commercial research or private study within the limits of fair dealing. The publisher or other rights-holder may allow further reproduction and re-use of this version - refer to the White Rose Research Online record for this item. Where records identify the publisher as the copyright holder, users can verify any specific terms of use on the publisher’s website. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ ImaGiNe Seldinger: first simulator for Seldinger technique and angiography training V. Luboz, Y. Zhang, S. Johnson, Y. Song, C. Kilkenny, C. Hunt, H. Woolnough, S. Guediri, J. Zhai, T. Odetoyinbo, P. Littler, A.
    [Show full text]
  • IVUS Imaging Catheters Reference Guide
    IVUS Imaging Catheters Reference Guide Peripheral Catheter Coronary Catheter Coronary Catheter Intracardiac Catheter OptiCross™ 18 OptiCross 6 OptiCross Ultra ICE™ Transducer 30 MHz 40 MHz 40 MHz 9 MHz Frequency Order Number H7493932800180 H7495181160 H749518110 M00499000 SFA, Popliteal, Typical Use Coronary Coronary Intracardiac Tibial, Renal Maximum Diameter 12 mm 6 mm 6 mm 50 mm Penetration Prep Location Proximal Proximal Proximal Distal Catheter 15 cm 15 cm 15 cm n/a Telescoping Length Sled Pullback Length 10 cm 10 cm 10 cm n/a Distance from 2.0 cm 2.0 cm 2.0 cm 1.0 cm Transducer to Tip Guidewire Lumen 1.6 cm 1.6 cm 1.6 cm n/a Length Guidewire ≤ 0.018" ≤ 0.014" ≤ 0.014" n/a Compatibility Sheath Compatibility 6 F 6 F 5 F 9 F (with max wire) Guide Catheter 6 F (ID ≥ 0.068") 6 F (ID ≥ 0.064") 5 F (ID ≥ 0.058") n/a Compatibility Crossing Profile 3.5 F 3.1 F 3.1 F n/a Imaging Window 2.9 F 2.9 F 2.6 F 9.0 F Profile Entry Profile 1.6 F 1.3 F 2.0 F 9.0 F Working Length 135 cm 135 cm 135 cm 110 cm OPTICROSS™ 18 CATHETER AND MDU5 PLUS BAG OPTICROSS 6 40 MHZ CORONARY IMAGING CATHETER CAUTION Federal law (USA) restricts this device to sale by or on the order of a physician. Rx only. Prior to use, please see the CAUTION: Federal law (USA) restricts this device to sale by or on the order of a physician.
    [Show full text]
  • Open Seldinger-Guided Peripheral Femoro-Femoral Cannulation
    Chen et al. Journal of Cardiothoracic Surgery (2021) 16:199 https://doi.org/10.1186/s13019-021-01584-x RESEARCH ARTICLE Open Access Open Seldinger-guided peripheral femoro- femoral cannulation technique for totally endoscopic cardiac surgery Yi Chen1,2, Liang-wan Chen1, Xiao-fu Dai1 and Xue-shan Huang1,2* Abstract Background: The cannulation technique used in totally endoscopic cardiac surgery has a significant impact on the overall prognosis of patients. However, there are no large cohort studies to discuss it. Here we report on our research of using open Seldinger-guided technique to establish femoro-femoral cardiopulmonary bypass during totally endoscopic cardiac surgery and evaluate its safety and efficacy. Methods: The institutional database from 2017 to 2020 was retrospectively reviewed to find cases in which totally endoscopic cardiac surgery was performed. We identified 214 consecutive patients who underwent totally endoscopic cardiac surgery with peripheral femoro-femoral cannulation. All patients underwent femoral artery cannulation. Of these, 201 were cannulated in the femoral vein and 13 were cannulated in the femoral vein combined with internal jugular cannulation. The technique involves surgically exposing the femoral vessel, setting up purse-string over the vessels and then inserting a guidewire into the femoral vessel without a vascular incision, followed by exchange of the guidewire with a cannula. Results: Surgery indications included mitral valve disease in 82.71% (177/214), atrial septal defect in 11.68% (25/214) and tricuspid regurgitation in the remaining 5.61% (12/214). Hospital survival was 98.60% (211/214). There were no cases of stroke and postoperative limb ischaemia.
    [Show full text]
  • Emergency Management of the DKA Patient
    COMMON EMERGENCY ROOM PROCEDURES Garret Pachtinger, VMD, DACVECC Associate, BluePearl PA Co-Founder, VETgirl ABDOMINOCENTESIS Abdominocentesis is a minimally invasive, inexpensive, diagnostic and potentially therapeutic procedure for patients with ascites. Evaluation of the fluid aids in diagnosis and helps guide treatment. Abdominal effusion is classified as a transudate, modified transudate, or exudate based on the cellularity and protein content of the fluid. Transudates (protein concentration < 25 g/l, nucleated cell count < 1000/l (1 x 109/l)), are commonly due to causes including hypoalbuminemia and early congestive heart failure. Modified transudates (protein concentration < 35 g/l, cell count < 5000/l (5 x 109/l)) result from increased hydrostatic pressure (right-sided congestive heart failure, left- sided congestive heart failure in cats), decreased oncotic pressure (hypoalbuminemia) or lymphatic obstruction (neoplasia). Exudates (protein concentration > 30–35 g/l, cell count > 5000/l (5 x 109/l), are found with causes including sepsis, feline infectious peritonitis (FIP), neoplasia, lung-lobe torsion, and pancreatitis. Along with cellularity and protein content, biochemical evaluation of the fluid for creatinine, potassium, bilirubin, lactate and glucose can aid in the diagnosis of various conditions, including uroabdomen, bile peritonitis, and septic peritonitis. The equipment needed to perform an abdominocentesis includes clippers, antimicrobial scrub, 70% ethyl alcohol, sterile gloves, 18 – 22 gauge, 1 - 1 ½ inch needles, extension tubing, 20 – 60 ml syringes (depending on size of the patient), and sterile EDTA and red top tubes for sample collection. To perform an abdominocentesis, the patient is placed in left lateral (to allow the spleen to fall away from midline) or sternal recumbency.
    [Show full text]
  • Guidelines for Performing Ultrasound Guided Vascular Cannulation
    GUIDELINES AND STANDARDS Guidelines for Performing Ultrasound Guided Vascular Cannulation: Recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists Christopher A. Troianos, MD, Gregg S. Hartman, MD, Kathryn E. Glas, MD, MBA, FASE, Nikolaos J. Skubas, MD, FASE, Robert T. Eberhardt, MD, Jennifer D. Walker, MD, and Scott T. Reeves, MD, MBA, FASE, for the Councils on Intraoperative Echocardiography and Vascular Ultrasound of the American Society of Echocardiography, Pittsburgh, Pennsylvania; Lebanon, New Hampshire; Atlanta, Georgia; New York, New York; Boston, Massachusetts; and Charleston, South Carolina (J Am Soc Echocardiogr 2011;24:1291-318.) Keywords: Anatomy, Artery, Cannulation, Femoral, Guidelines, Internal jugular, Pediatric, Peripheral, Subclavian, Ultrasound, Vascular, Venous TABLE OF CONTENTS 7.1. Anatomic Considerations 1297 7.2. Cannulation Technique 1298 Abbreviations 1292 7.3. Complications 1298 7.4. Recommendation for IJ Vein Cannulation 1300 1. Introduction 1291 8. Subclavian Vein Cannulation 1300 2. Methodology and Evidence Review 1292 8.1. Anatomic Considerations 1300 3. Ultrasound-Guided Vascular Cannulation 1292 8.2. Cannulation Technique 1300 4. Ultrasound Principles for Needle-Guided Catheter Placement 1292 8.3. Complications 1301 5. Real-Time Imaging Versus Static Imaging 1294 8.4. Recommendation for SC Vein Cannulation 1302 6. Vessel Identification 1297 9. Femoral Vein Cannulation 1302 7. Internal Jugular Vein Cannulation 1297 9.1. Anatomic Considerations 1302 9.2. Cannulation Technique 1302 9.3. Complications 1303 From the Department of Anesthesiology, West Penn Allegheny Health System, 9.4. Recommendation for FV Cannulation 1303 Pittsburgh, Pennsylvania (C.A.T.); the Department of Anesthesiology, 10. Pediatric Ultrasound Guidance 1303 Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire (G.S.H.); the 10.1.
    [Show full text]
  • Venous Cutdown Versus the Seldinger Technique for Placement of Totally Implantable Venous Access Ports (Protocol)
    Cochrane Database of Systematic Reviews Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports (Protocol) Hsu CCT, Kwan GNC, van Driel ML, Rophael JA Hsu CCT, Kwan GNC, van Driel ML, Rophael JA. Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD008942. DOI: 10.1002/14651858.CD008942. www.cochranelibrary.com Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports (Protocol) Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 BACKGROUND .................................... 1 OBJECTIVES ..................................... 3 METHODS ...................................... 3 REFERENCES ..................................... 5 CONTRIBUTIONSOFAUTHORS . 6 DECLARATIONSOFINTEREST . 6 SOURCESOFSUPPORT . 6 Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports (Protocol) i Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. [Intervention Protocol] Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports Charlie C-T Hsu1, Gigi NC Kwan2, Mieke L van Driel3, John A Rophael4 1The Alfred Hospital, Prahran, Australia. 2Box Hill Hospital, Box Hill, Australia. 3Faculty of Health
    [Show full text]
  • Venaseal Closure System Product Code: VS-402
    VenaSealTM Closure System Product Code: VS-402 Instructions for Use TABLE OF CONTENTS 1. DESCRIPTION ....................................................................................................................... 1 2. INTENDED USE/INDICATIONS .......................................................................................... 2 3. CONTRAINDICATIONS ....................................................................................................... 2 4. WARNINGS ............................................................................................................................ 3 5. PRECAUTIONS ...................................................................................................................... 3 6. POTENTIAL ADVERSE EFFECTS OF THE DEVICE ON HEALTH ................................ 4 7. SUMMARY OF CLINICAL STUDIES ................................................................................. 5 8. PRIMARY CLINICAL STUDY (VECLOSE) ....................................................................... 5 9. HOW SUPPLIED .................................................................................................................. 16 10. STORAGE AND HANDLING ......................................................................................... 19 11. DIRECTIONS FOR USE .................................................................................................. 19 12. SYMBOL LEGEND .........................................................................................................
    [Show full text]
  • Pleural Procedures and Thoracic Ultrasound: British Thorax: First Published As 10.1136/Thx.2010.137026 on 9 August 2010
    BTS guidelines Pleural procedures and thoracic ultrasound: British Thorax: first published as 10.1136/thx.2010.137026 on 9 August 2010. Downloaded from Thoracic Society pleural disease guideline 2010 Tom Havelock,1 Richard Teoh,2 Diane Laws,3 Fergus Gleeson,4 on behalf of the BTS Pleural Disease Guideline Group < Supplementary appendices BACKGROUND curriculum for core medical training and trainees 1-4 are published online only. In hospital practice, pleural aspiration (thor- should be expected to describe the procedure and To view these files please visit acocentesis) and chest drain insertion may be complications in an examination. The trainee should the journal online (http://thorax. bmj.com). required in many different clinical settings for ensure each procedure is documented in their log a variety of indications. Doctors in most specialities book and signed by the trainer. A Directly Observed 1Wellcome Trust Clinical Research Facility, Southampton will be exposed to patients requiring pleural Practice (DOP) assessment should be completed in General Hospital, Southampton, drainage and need to be aware of safe techniques. support of this. UK There have been many reports of the dangers of Studies of training involving didactic lectures, 2Department of Respiratory large-bore chest drains and it had been anticipated manikin practice and following protocols, including Medicine, Castle Hill Hospital, that, with the previous guidelines, better training use of sedation and anaesthesia, have shown the Cottingham, East Yorkshire, UK 3Department of Thoracic and the advent of small-bore Seldinger technique risk of complications and patient pain and anxiety 4 Medicine, Royal Bournemouth chest drains, there would have been an improve- can be reduced and trainee knowledge and confi- Hospital, Bournemouth, UK ment.
    [Show full text]
  • Outcomes of Using a Modified Seldinger Technique for Long Term Intravenous Therapy in Hospitalized Patients with Difficult Venous Access
    RE S E A RC H Outcomes of Using a Modified Seldinger Technique for Long Term Intravenous Therapy in Hospitalized Patients with Difficult Venous Access William G. Warrington Jr., PhD, RN, CCRP Nurse Scientist at the Center for Nursing Research, Orlando Health, Orlando, FL Daleen Aragon Penoyer, PhD, RN, CCRP, FCCM Director of the Center for Nursing Research, Orlando Health, Orlando, FL Teresa A. Kamps, RN, CRNI, VA-BC Clinical Support Manager, Access Scientific, Inc., San Diego, CA Ella H. Van Hoeck, RN, VA-BC Registered Nurse, PICC Department, Orlando Regional Medical Center, a part of Orlando Health, Orlando, FL Abstract Background and Significance: Many hospitalized patients require an intravenous (IV) catheter to maintain vascular ac- cess or for administration of fluids and medications. The best approach to attaining peripheral intravenous (PIV) access for long term therapy is unknown, particularly in patients with a history of difficult IV placement. Purpose: To measure clinical outcomes using a Modified Seldinger Technique (MST) with ultrasound (US) guidance to achieve and maintain PIV for long term IV therapy. Methods: Subjects were patients with a history of difficult peripheral intravenous catheter placement and need for IV therapy longer than 72 hours. Modified Seldinger Technique was used with US guidance to place all PIVs in the deep veins of the upper extremities. Results: A convenience sample of 157 subjects was enrolled in the study. Mean dwell time for catheter duration was seven days. First attempt placement success was 95%, 88.5% of patients had completion of IV therapy, and a low overall com- plication rate (9.57/1000 catheter days).
    [Show full text]